
Two Hundred Million Dollars of Customer Acquisition: Hone Health, Customer Value Financing and the Longevity Clinic Boom
Dr. Dereck Mush, MD, MBAHone Health is a physician-led longevity platform founded in 2020, according to Fortune on November 18, 2026. The company lists treatment areas including testosterone replacement therapy, menopause hormone therapy, weight management, peptides, thyroid, heart health and sexual health. Its proprietary AI clinical platform is Longevity OS. Hone reports more than 200,000 patients treated, 750,000 tests administered and 25 million health markers processed (company-reported). It says it plans a physician-supervised peptide program.
Co-founder and CEO
How Hone Health got here, step by step.
January 2025
Hone announced a $33 million Series A. MarcyPen Capital Partners led the round, a role disclosed in the November 18, 2026 announcement.
18 November 2026
Hone announced a $28 million Series A equity extension led by MarcyPen Capital Partners and $200 million in growth financing from General Catalyst's Customer Value Fund. Total equity funding reached $65 million. Hone Black was publicly announced the same day.

Dr. Dereck Mush, MD, MBAMentions Hone Health
Related companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: